FORTRESS BIOTECH INCORPORATED (FBIO)

On June 30, 2026, BlackRock, Inc. (Trades, Portfolio) executed a significant reduction in its position in BridgeBio Pharma Inc (BBIO), selling 4,473,995 shares

FIBROBIOLOGICS ($FBLG) posted quarterly earnings results for Q2 2026 on Friday, July 31st. The company reported earnings of -$0.66 per share, beating estimates of -$0.73 by $0.07. The company also reported revenue of $0, equaling estimates of $0 by $0.You can see Quiver Quantitative's $FBLG ...

Net loss reached $9,117,000 on operating expenses of $9,101,000 as cash fell to $3,515,000; FibroBiologics advances its CYWC628 diabetic foot ulcer trial while raising capital and detailing warrant overhang and a Nasdaq delisting determination.

The headline numbers for First Business Financial Services (FBIZ) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Meta (META) being coy about future AI spending isn't what the market wants to hear as overspending fears rattle tech stocks. Yet that's what the market got — and Meta received another earnings day stock plunge in return.